Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) ROCE %: 1.48% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:EGEPO Nasmed Ozel Saglik Hizmetleri Ticaret AS IST:EGEPO
73 GF Score
Price ₺18.28
GF Value ₺8.41
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Nasmed Ozelglik Hizmetleri Ticaret AS ROCE %?

Nasmed Ozelglik Hizmetleri Ticaret AS IST:EGEPO -2.45% 73 ROCE % is 1.48% as of Dec. 2025. GuruFocus rates IST:EGEPO with a GF Score™ of 73/100 and a GF Value™ of ₺8.41 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nasmed Ozelglik Hizmetleri Ticaret AS's annualized ROCE % for the quarter that ended in Dec. 2025 was 1.48%.

Nasmed Ozelglik Hizmetleri Ticaret AS  (IST:EGEPO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nasmed Ozelglik Hizmetleri Ticaret AS ROCE % Related Terms

Nasmed Ozelglik Hizmetleri Ticaret AS ROCE % Historical Data

* Premium members only.

The historical data trend for Nasmed Ozelglik Hizmetleri Ticaret AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nasmed Ozelglik Hizmetleri Ticaret AS ROCE % Chart

Nasmed Ozelglik Hizmetleri Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial 24.75 9.33 -16.36 12.09 -0.40

Nasmed Ozelglik Hizmetleri Ticaret AS Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.38 3.93 0.87 0.79 1.48
IST:EGEPO
73GF Score
Nasmed Ozel Saglik Hizmetleri Ticaret AS IST:EGEPO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nasmed Ozelglik Hizmetleri Ticaret AS ROCE % Calculation

Nasmed Ozelglik Hizmetleri Ticaret AS's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-7.208/( ( (1828.055 - 177.661) + (2220.102 - 228.82) )/ 2 )
=-7.208/( (1650.394+1991.282)/ 2 )
=-7.208/1820.838
=-0.40 %

Nasmed Ozelglik Hizmetleri Ticaret AS's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=29.708/( ( (2093.461 - 180.111) + (2309.289 - 202.149) )/ 2 )
=29.708/( ( 1913.35 + 2107.14 )/ 2 )
=29.708/2010.245
=1.48 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.48% mean?
Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) has a ROCE % of 1.48% as of Dec. 2025.
Is Nasmed Ozelglik Hizmetleri Ticaret AS's ROCE % too high?
Nasmed Ozelglik Hizmetleri Ticaret AS's current ROCE % is 1.48%. The Healthcare Providers & Services industry median ROCE % is 6.37. Nasmed Ozelglik Hizmetleri Ticaret AS's value of 1.48% is 76.7% below this industry median. Overall, Nasmed Ozelglik Hizmetleri Ticaret AS has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nasmed Ozelglik Hizmetleri Ticaret AS's ROCE % compare to HCA and THC?
Nasmed Ozelglik Hizmetleri Ticaret AS's ROCE % of 1.48% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.37. Nasmed Ozelglik Hizmetleri Ticaret AS's value of 1.48% is 76.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.37, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nasmed Ozelglik Hizmetleri Ticaret AS's current ROCE % of 1.48% is 76.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nasmed Ozelglik Hizmetleri Ticaret AS's current ROCE % is 1.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nasmed Ozelglik Hizmetleri Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺8.41, compared to a current price of ₺18.28 — trading 117.4% above its estimated fair value. The current ROCE % is 1.48% and 76.7% below the Healthcare Providers & Services industry median of 6.37. Nasmed Ozelglik Hizmetleri Ticaret AS's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO), the current ROCE % is 1.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nasmed Ozelglik Hizmetleri Ticaret AS (IST:EGEPO) Overvalued in 2026?

Based on GuruFocus' analysis, Nasmed Ozelglik Hizmetleri Ticaret AS stock appears to be overvalued. The current stock price of ₺18.28 is trading 117.4% above its estimated GF Value™ of ₺8.41. GuruFocus considers Nasmed Ozelglik Hizmetleri Ticaret AS to be Significantly Overvalued.

Key valuation signals for IST:EGEPO:

  • ROCE %: 1.48%
  • GF Value™: ₺8.41 vs. price of ₺18.28 (117.4% above fair value)
  • GF Score™: 73/100 with 7 warning signs
  • Industry Position: 76.7% below the Healthcare Providers & Services median

No single metric tells the full story. See the IST:EGEPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nasmed Ozelglik Hizmetleri Ticaret AS Business Description

Address Iller Bankasi Halide Edip Adivar Bulvar, 507. Sk. No:3, Izmir, TUR, 35270
Nasmed Ozel Saglik Hizmetleri Ticaret AS provides quality healthcare services. It arranges consultations, travel planning, accommodation, translation, and other relevant services for its patients 24/7.
73GF Score

Get the complete analysis for IST:EGEPO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺18.28
Price
₺8.41
GF Value